Switching From Adalimumab to a Biosimilar
Specialists in rheumatology, dermatology and gastrointestinal disease discuss the evidence on efficacy and safety on switching patient to an adalimumab biosimilar.
Source: hcplive.com
Stay updated with breaking news from Switching Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Specialists in rheumatology, dermatology and gastrointestinal disease discuss the evidence on efficacy and safety on switching patient to an adalimumab biosimilar.